Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthline
Recent studies suggest that GLP-1 receptor agonists, while primarily used for weight loss, may also impact mental health and behavior, potentially due to their effects on the brain’s reward systems.
Endocrinology, Diabetes, Metabolism April 30th 2024
MDLinx
This study highlights the role of avocados in enhancing diet quality and vegetable intake among adults with obesity, with no associated weight gain, suggesting a viable strategy for dietary improvement.
All Specialties April 30th 2024
TheBodyPro
The “Effectiveness of PrEPTECH” trial reveals telehealth’s potential and challenges in initiating and sustaining PrEP adherence among at-risk groups, emphasizing the necessity for integrated community support in healthcare strategies.
Infectious Diseases April 22nd 2024
HIT Consultant
Philips Respironics has established a consent decree with US regulators to ensure the safety and compliance of their sleep and respiratory care devices, focusing on stringent remediation and continued patient support amidst ongoing sales restrictions.
Internal Medicine April 22nd 2024
With a significant rise in meningococcal disease cases in 2023 and continuing into 2024, physicians must be alert for non-traditional symptoms such as septic arthritis and bacteremia to ensure timely and effective patient management.
Infectious Diseases April 18th 2024
Medical Professionals Reference (MPR)
Zevtera® (ceftobiprole medocaril) provides a significant advancement in treating serious bacterial infections, demonstrating high efficacy against both MRSA and MSSA in recent phase 3 clinical trials.